0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Policy & Risk Sign in to save

Environmental Pollution to Blame for Depressive Disorder?

Preprints.org 2021 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 35 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Mariana Segovia‐Mendoza, Mariana Segovia‐Mendoza, Margarita Isabel Palacios‐Arreola, Karen Elizabeth Nava‐Castro, Margarita Isabel Palacios‐Arreola, Karen Elizabeth Nava‐Castro, Margarita Isabel Palacios‐Arreola, Lenin Pavón, Enrique Becerril‐Villanueva, Jorge Morales‐Montor Mariana Segovia‐Mendoza, Karen Elizabeth Nava‐Castro, Jorge Morales‐Montor Jorge Morales‐Montor Omar Amador, Omar Amador, Jorge Morales‐Montor

Summary

This review examines the link between endocrine-disrupting chemicals (EDCs) — many of which leach from plastics — and the development of major depressive disorder. Animal studies show EDC exposure can alter brain chemistry, cause neurodegeneration, and produce depression-like behaviors. The authors call for more research into whether plastic-associated chemicals contribute to rising rates of depression in the general population.

Public concern has emerged about the effects of endocrine disruptor compounds (EDCs) on neuropsychiatric disorders. Preclinical evidence suggests that exposure to EDCs is associated with the development of the major depressive disorder (MDD) and could result in neural degeneration. The interaction of EDCs with hormonal receptors is the best-described mechanism of their biological activity. However, the dysregulation of the hypothalamic-pituitary-gonadal adrenal axis has been reported and linked to neurological disorders. On the other hand, at a worldwide level and in Mexico, the incidence of MDD has recently been increasing. Of note, in Mexico, there are no clinical associations on blood levels of EDCs and the incidence of the MDD. Methodology: Thus, we quantified for the first time the serum levels of parent compounds of two bisphenols and four phthalates in patients with MDD. Results: The levels of di-ethyl-hexyl-phthalate (DEHP), butyl-benzyl-phthalate (BBP), di-n-butyl phthalate (DBP), and di-ethyl-phthalate (DEP), bisphenol A (BPA), and bisphenol S (BPS) were determined with a gas chromatograph-mass spectrometer. Results/ conclusion: We found significant differences between concentrations of BBP between controls and patients with MDD.

Sign in to start a discussion.

Share this paper